About Us
About Us
The Iylon Foundation is the philanthropic arm of Iylon Precision Oncology, dedicated to advancing precision oncology by providing personalized cancer treatment consultations worldwide. Using the latest research and technology, we aim to improve patient outcomes across diverse locations. As a nonprofit, our mission is to guide and support cancer patients through this revolutionary, genetics-based approach to therapy. We collaborate with Iylon Precision Oncology and a network of experts to offer comprehensive support. Currently, we have funds to aid Rhode Island patients but seek partnerships beyond state lines to expand our reach and assist more patients nationwide. Join us in improving cancer care through innovation, compassion, and community support for a brighter future.
Leadership working for a Better SOLUTION
Mr. John Tarantino
Mr. John Tarantino
Mr. John Tarantino
John Tarantino is the Chief Executive Officer (CEO) of Iylon Precision Oncology and a longtime supporter of fair healthcare access. With extensive leadership experience in business and community organizations, John brings a vision of making cutting-edge cancer treatment available to all patients in Rhode Island, regardless of their financial situation. His leadership in Iylon and the Iylon Foundation reflects a deep commitment to both innovation and compassion.
Ms. Poornima Bhat
Mr. John Tarantino
Mr. John Tarantino
Poornima Bhat is a healthcare leader with extensive experience in patient advocacy and organizational management. Her work focuses on building connections between patients, healthcare providers, and community organizations to ensure that care is accessible and patient-centered. At the Iylon Foundation, Poornima applies her expertise in advocacy, program development, and community engagement to help expand the reach of life-saving cancer care.
Dr. Sendurai Mani
Mr. John Tarantino
Dr. Sendurai Mani
Dr. Sendurai Mani is a distinguished cancer researcher and Chief Scientific Officer of Iylon Precision Oncology. Internationally recognized for his groundbreaking work in cancer biology, Dr. Mani brings scientific expertise and unwavering dedication to patient-focused innovation. His role on the Iylon Foundation board helps ensure that the foundation’s mission remains strong in advancing cancer science while supporting the patients who need it most.